Immunocine Cancer Center

Immunocine Cancer Center provides a personalized dendritic cell immunotherapy for patients with solid tumors. The treatment uses the patient's own cells, processed to load dendritic cells with cancer-specific mRNA and proteins. This approach trains the immune system to target cancer cells precisely throughout the body.

The protocol spans six weeks in Cancun, Mexico, with three phases: pre-treatment preparation to optimize immune function, the core Immunocine Dendritic Cell Treatment, and post-treatment support including scans and boosters. Patients receive three treatments two weeks apart, with options to stay continuously or visit twice. The process begins with blood draws, biopsies, and white blood cell stimulation using natural cytokines.

This integrated method focuses on sustainable immune activation without foreign compounds. It applies to various cancer types and stages, delivered in a certified cleanroom lab by oncologists trained in the U.S. and Mexico.